New NASH (Fatty Liver) Clinical Trials

The Effect of a Probiotic on Hepatic Steatosis

Non-alcoholic fatty liver disease (NAFLD) is an accumulation of fat and fibrous tissue in the liver. It is the most common cause of chronic liver disease in the United States. The exact cause of NAFLD is unknown, but it is more common among people with conditions such as [...]

New Hepatitis B Clinical Trials

Adding Adefovir Dipivoxil Versus Switching to Entecavir in Patients With Lamivudine-Resistant Chronic Hepatitis BAntiviral resistance mutations limit the efficacy of therapy for chronic hepatitis B. At year 2, resistance to adefovir may occur as high as 25% in patients with history of lamivudine resistance. Resistance to entecavir is reported to be 10% in lamivudine refractory [...]

New Hepatitis C Clinical Trials

Nowaday hepatitis C response to the treatment is between 50 and 80 % . Here I choose a list of new trials to inprove the response and the qol of patients with HEP C.
Vaccine :
Pevion Biotech has designed a therapeutic vaccine to treat patients who suffer from chronic hepatitis C virus infection. The vaccine is [...]

Lasker Awards Winners Announced

NEW YORK (AP) — Two researchers who opened up the field of heart-valve replacement and a scientist who discovered a type of cell that plays a key role in the immune system have won prestigious medical prizes.
The $150,000 Albert Lasker Medical Research Awards will be presented Sept. 28 in New York by the Albert [...]

HIV Vaccine Trials Produce Encouraging Results

Vical Incorporated (Nasdaq: VICL) announced today that results from a series of HIV vaccine Phase 2a clinical trials, using a plasmid DNA (pDNA) vaccine developed by the NIH Vaccine Research Center and manufactured by Vical, reinforced previously reported Phase 1 conclusions that a “DNA prime-adenoviral vector boost” vaccine regimen was safe and well-tolerated, and was [...]

News: Abbott Enrolls First Patient In World’s First Clinical Trial Designed To Study Drug Eluting Stent Treatment In Women

Abbott (NYSE: ABT) today announced that the first patient was enrolled in its XIENCE V SPIRIT WOMEN clinical trial, the world’s first clinical trial designed to study the safety and effectiveness of drug eluting stent treatment in women. Liliana Grinfeld, M.D., of the Hospital Italiano in Buenos Aires, Argentina, performed the first procedure.
The goal of [...]

News : Alzheimer´s vaccine

The Alzheimer’s vaccine known as Affitope AD01 from Affiris has now entered the clinical phase of its development. All relevant regulatory and statutory approvals have been secured and this innovative treatment is now being tested on humans for the first time. This development means that the 8.5 million-Euro venture capital finance agreement the company concluded [...]